Showing results (1201-1210 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|May 8, 2002
Quality-of-life assessment in osteoporosis: health-status and preference-based measuresAnna N A Tosteson, Cristina S HammondPharmacoeconomics|May 8, 2002
Economic evaluation of gemcitabine alone and in combination with cisplatin in the treatment of nonsmall cell lung cancerM Lees, M Aristides, N Maniadakis, et al.Pharmacoeconomics|September 11, 2001
Highly active antiretroviral therapy: pharmacoeconomic issues in the management of HIV infectionP Sendi, A J Palmer, A Gafni, et al.Pharmacoeconomics|September 11, 2001
Economic and health-related quality of life considerations of new therapies in Parkinson's diseaseL M Rubenstein, A DeLeo, E A ChrischillesPharmacoeconomics|September 11, 2001
Iatrogenic cost factors incorporating mild and moderate adverse events in the economic comparison of aceclofenac and other NSAIDsF Peris, E Martínez, X Badia, et al.Pharmacoeconomics|February 26, 2003
Specialist nurse management programmes: economic benefits in the management of heart failureSimon Stewart, John D HorowitzPharmacoeconomics|February 26, 2003
A study of influenza and influenza-related complications among children in a large US health insurance plan databaseJeanne Loughlin, Nick Poulios, Pavel Napalkov, et al.Pharmacoeconomics|February 26, 2003
Health-related quality-of-life assessments in patients with advanced cancer of the prostateJan AdolfssonPharmacoeconomics|April 8, 2003
Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicamManouche TavakoliPharmacoeconomics|August 12, 2003
Recurrent genital herpes treatments and their impact on quality of lifeMathijs H Brentjens, Kimberly A Yeung-Yue, Patricia C Lee, et al.Pageof 336